Leveraging the EHR to Promote Pharmacy Adoption of Dosing Best Practices and Reduce Parent Errors in Administering Pediatric Liquid Medications: A Health Literacy-Informed Approach

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Medication Dosing Errors
  • Age: Between 18 - 100 Years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    Caregiver/Child
    1. English or Spanish-speaking
    2. Parent or legal guardian of a child prescribed a liquid medicine in the NYU Langone Health-Brooklyn or Bellevue ED, general outpatient pediatric clinic, or specialty care clinics
    3. Child discharged home with a Rx for 1 or more daily liquid medication dose =10mL/2tsp, for use as a chronic or short course (=14 days) medication
    4. Primary person who will administer child's medications
    5. Access to a smartphone that can take photos and send/receive text messages
    6. Willingness and ability to participate
    Pharmacy staff
    1. Works at a pharmacy that dispensed index medicine to one of our study participants

You may not be eligible for this study if the following are true:

  • Caregiver/Child
    1. Does not have a working phone number
    2. Not able to return for in-person follow-up visit
    3. Was told to stop medication by provider after doctor/ED visit
    4. Parent no longer having index medication bottle
    5. Uncorrected hearing impairment
    6. Self-reported poor visual acuity
    Pharmacy staff
    1. Staff with no responsibility in determining unit of measure to include on Rx's or type and capacity of the dosing tool to dispense for pediatric oral liquid medications



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.